ArticleBritish journal of cancer2010

Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib.

T W Flaig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.